During the past decade, South Texas Research Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Texas Research Institute" #1 sponsor was "Madrigal Pharmaceuticals, Inc." with 3 trials, followed by "Altimmune, Inc." with 2 trials sponsored, "Hepion Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Galectin Therapeutics Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Research Institute" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "South Texas Research Institute" are "Non-Alcoholic Fatty Liver Disease" (4 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Cirrhosis" (1 trials), "Fibrosis, Liver" (1 trials) and "HCC" (1 trials). Many other conditions were trialed in "South Texas Research Institute" in a lesser frequency.

Most popular intervention types in "South Texas Research Institute" are "Drug" (14 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "ALT-801" (2 trials), "Resmetirom" (2 trials), "BFKB8488A" (1 trials) and "BI 456906" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Research Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "South Texas Research Institute". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in South Texas Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Research Institute, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".